1. Home
  2. IH vs OVID Comparison

IH vs OVID Comparison

Compare IH & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

N/A

Current Price

$1.74

Market Cap

116.0M

Sector

Real Estate

ML Signal

N/A

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
OVID
Founded
1996
2014
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
117.5M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
IH
OVID
Price
$1.74
$1.66
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$3.40
AVG Volume (30 Days)
10.7K
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.88%
N/A
EPS Growth
N/A
3.90
EPS
N/A
N/A
Revenue
N/A
$566,000.00
Revenue This Year
$39.02
$1,077.56
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$0.24
52 Week High
$3.60
$2.01

Technical Indicators

Market Signals
Indicator
IH
OVID
Relative Strength Index (RSI) 39.51 59.01
Support Level $1.75 $1.43
Resistance Level $2.29 $1.85
Average True Range (ATR) 0.10 0.11
MACD -0.01 0.03
Stochastic Oscillator 14.02 98.55

Price Performance

Historical Comparison
IH
OVID

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: